| Metric | შპს ვიტამინი 2017 | შპს იმპექსფარმი | შპს ფარმაცევტული სახლი + | შპს SmartPharm | შპს პსპ ფარმა |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue | ₾110.9m₾92.7m | ₾102.5m₾109.4m | ₾61.6m₾65.5m | ₾31.6m₾33.9m | ₾775.6m₾744.8m |
| Revenue growth | 19.6% | -6.4% | -5.8% | -6.8% | 4.1% |
| Profitability | |||||
| EBITDA | ₾6.4m₾2.8m | ₾4.2m₾7.3m | -₾11.7m-₾2.7m | ₾3.3m₾4.0m | ₾57.8m₾55.5m |
| EBITDA margin | 5.8%3.0% | 4.1%6.7% | -18.9%-4.1% | 10.4%11.7% | 7.5%7.5% |
| Net profit | ₾6.0m₾2.8m | ₾153k₾10.2m | -₾11.2m-₾3.1m | ₾2.8m₾4.1m | ₾36.0m₾51.4m |
| Net margin | 5.4%3.1% | 0.1%9.3% | -18.2%-4.8% | 8.8%12.1% | 4.6%6.9% |
| Balance sheet | |||||
| Total assets | ₾15.4m₾9.3m | ₾91.0m₾86.7m | ₾66.5m₾48.9m | ₾13.4m₾15.1m | ₾627.4m₾636.9m |
| Total equity | ₾12.8m₾8.0m | ₾60.1m₾63.2m | -₾17.3m-₾6.0m | ₾11.6m₾11.0m | ₾326.5m₾305.2m |
| ROE | 46.7%35.8% | 0.3%16.1% | — | 23.9%37.0% | 11.0%16.8% |